Forbion Capital Partners has 10 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months. It led 8 of the 12 rounds it joined. Its most recent investment on record is CellCentric's $220M Series B+ round in May 2026, alongside Venrock Healthcare Capital Partners, Sofinnova Partners, RA Capital Management and 5 others. By category, its portfolio leans toward Health and bio (9) and Commerce and retail (1). It has co-invested with BioGeneration Ventures, Jeito Capital and Novartis Venture Fund, most often BioGeneration Ventures (4 rounds).

Funds raised

Venture funds Forbion Capital Partners raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

What Forbion Capital Partners invests in

• Health and bio · 9 · 90%
• Commerce and retail · 1 · 10%
• AI agents · 1 · 10%
• Legal and compliance · 1 · 10%
• Cybersecurity · 1 · 10%

Forbion Capital Partners recent investments

Company	Round	Date	Alongside
CCellCentric	Series B+ · $220M	May 6, 2026	Venrock Healthcare Capital Partners (lead), Sofinnova Partners, RA Capital Management +5
TTropic Biosciences	Series B+ · $105M · lead	Mar 12, 2026	Temasek, Sucden Ventures, Polaris +6
CCellCentric	Series B+ · $120M · lead	May 19, 2025	RA Capital Management (lead), BrightEdge - American Cancer Society, Avego Management
AAzafaros	Series B+ · $150M · lead	May 13, 2025	Seroba Life Sciences, Schroders Capital, Pictet Alternative Advisors +2
CCatalYm	Series B+ · $150M	Jul 16, 2024	Vesalius Biocapital Partners, Omega Funds, Novartis Venture Fund +5
EEngrail Therapeutics	Series B+ · $157M · lead	Mar 19, 2024	Ysios Capital, RiverVest, Red Tree Venture Capital +6
MMariana Oncology	Series B+ · $175M · lead	Sep 7, 2023	Surveyor Capital, RA Capital Management, Nextech Invest +4
NNoema Pharma	Series B+ · $112M · lead	Mar 7, 2023	UPMC Enterprises, Sofinnova Partners, Polaris +3

How Forbion Capital Partners invests

Share is of the 12 rounds on Recent Funding that name Forbion Capital Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Forbion Capital Partners portfolio companies

• CCellCentric$220MSeries B+ · May 2026
• TTropic Biosciences$105MSeries B+ · Mar 2026
• AAzafaros$150MSeries B+ · May 2025
• CCatalYm$150MSeries B+ · Jul 2024
• EEngrail Therapeutics$157MSeries B+ · Mar 2024
• MMariana Oncology$175MSeries B+ · Sep 2023
• NNoema Pharma$112MSeries B+ · Mar 2023
• AAnaveon$120MSeries B+ · Dec 2021
• KKorsanabacker
• FF2Gbacker

Most frequent co-investors

• BBioGeneration Ventures4 shared rounds · last May 13, 2025
• JJeito Capital4 shared rounds · last May 13, 2025
• NNovartis Venture Fund4 shared rounds · last Jul 16, 2024
• RRA Capital Management3 shared rounds · last May 6, 2026
• VVesalius Biocapital Partners3 shared rounds · last Jul 16, 2024
• BBrightEdge - American Cancer Society2 shared rounds · last May 6, 2026
• SSofinnova Partners2 shared rounds · last May 6, 2026
• PPolaris2 shared rounds · last Mar 12, 2026
• BBrandon Capital2 shared rounds · last Jul 16, 2024
• GGilde Healthcare2 shared rounds · last Jul 16, 2024
• Ccoparion2 shared rounds · last Nov 22, 2022
• FFidelity1 shared round · last May 6, 2026

Similar investors

• AARCH Venture Partners11 companies · 6 deals in 12 mo
• CCatalio11 companies · 4 deals in 12 mo
• Rredalpine11 companies · 4 deals in 12 mo
• AAlleyCorp11 companies · 3 deals in 12 mo
• OOctopus Ventures11 companies · 2 deals in 12 mo
• FForesite Capital11 companies

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Forbion Capital Partners, which is a subset of its real portfolio. API: /api/v1/investors/forbion-capital-partners (get a free API key). More: the most active VC firms and new venture capital funds.